Global Drugs For Herpes Labialis (Oral Herpes) Market Size, Status and Forecast 2022

September 2017 | 107 pages | ID: G48A183B915EN
QYResearch

Abstracts

This report studies the global Drugs For Herpes Labialis (Oral Herpes) market, analyzes and researches the Drugs For Herpes Labialis (Oral Herpes) development status and forecast in United States, EU, Japan, China, India and Southeast Asia.
This report focuses on the top players in global market, like

• GSK
• Novartis
• Teva
• Mylan
• Cadila
• Apotex
• Daewoong Pharmaceutical
• Livzon
• Luoxin
• Med shine
• Bayer (Campho Phenique)
• Blistex
• Kelun Group
• Hikma
• Haiwang
• Carmex
• Cipher

Market segment by Regions/Countries, this report covers

• United States
• EU
• Japan
• China
• India
• Southeast Asia

Market segment by Type, Drugs For Herpes Labialis (Oral Herpes) can be split into

• Valacyclovir
• Aciclovir
• Famciclovir
• Docosanol
• Other

Market segment by Application, Drugs For Herpes Labialis (Oral Herpes) can be split into

• External Use
• Oral
• Injection

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Global Drugs For Herpes Labialis (Oral Herpes) Market Size, Status and Forecast 2022

1 INDUSTRY OVERVIEW OF DRUGS FOR HERPES LABIALIS (ORAL HERPES)

1.1 Drugs For Herpes Labialis (Oral Herpes) Market Overview
  1.1.1 Drugs For Herpes Labialis (Oral Herpes) Product Scope
  1.1.2 Market Status and Outlook
1.2 Global Drugs For Herpes Labialis (Oral Herpes) Market Size and Analysis by Regions
  1.2.1 United States
  1.2.2 EU
  1.2.3 Japan
  1.2.4 China
  1.2.5 India
  1.2.6 Southeast Asia
1.3 Drugs For Herpes Labialis (Oral Herpes) Market by Type
  1.3.1 Valacyclovir
  1.3.2 Aciclovir
  1.3.3 Famciclovir
  1.3.4 Docosanol
  1.3.5 Other
1.4 Drugs For Herpes Labialis (Oral Herpes) Market by End Users/Application
  1.4.1 External Use
  1.4.2 Oral
  1.4.3 Injection

2 GLOBAL DRUGS FOR HERPES LABIALIS (ORAL HERPES) COMPETITION ANALYSIS BY PLAYERS

2.1 Drugs For Herpes Labialis (Oral Herpes) Market Size (Value) by Players (2016 and 2017)
2.2 Competitive Status and Trend
  2.2.1 Market Concentration Rate
  2.2.2 Product/Service Differences
  2.2.3 New Entrants
  2.2.4 The Technology Trends in Future

3 COMPANY (TOP PLAYERS) PROFILES

3.1 GSK
  3.1.1 Company Profile
  3.1.2 Main Business/Business Overview
  3.1.3 Products, Services and Solutions
  3.1.4 Drugs For Herpes Labialis (Oral Herpes) Revenue (Value) (2012-2017)
  3.1.5 Recent Developments
3.2 Novartis
  3.2.1 Company Profile
  3.2.2 Main Business/Business Overview
  3.2.3 Products, Services and Solutions
  3.2.4 Drugs For Herpes Labialis (Oral Herpes) Revenue (Value) (2012-2017)
  3.2.5 Recent Developments
3.3 Teva
  3.3.1 Company Profile
  3.3.2 Main Business/Business Overview
  3.3.3 Products, Services and Solutions
  3.3.4 Drugs For Herpes Labialis (Oral Herpes) Revenue (Value) (2012-2017)
  3.3.5 Recent Developments
3.4 Mylan
  3.4.1 Company Profile
  3.4.2 Main Business/Business Overview
  3.4.3 Products, Services and Solutions
  3.4.4 Drugs For Herpes Labialis (Oral Herpes) Revenue (Value) (2012-2017)
  3.4.5 Recent Developments
3.5 Cadila
  3.5.1 Company Profile
  3.5.2 Main Business/Business Overview
  3.5.3 Products, Services and Solutions
  3.5.4 Drugs For Herpes Labialis (Oral Herpes) Revenue (Value) (2012-2017)
  3.5.5 Recent Developments
3.6 Apotex
  3.6.1 Company Profile
  3.6.2 Main Business/Business Overview
  3.6.3 Products, Services and Solutions
  3.6.4 Drugs For Herpes Labialis (Oral Herpes) Revenue (Value) (2012-2017)
  3.6.5 Recent Developments
3.7 Daewoong Pharmaceutical
  3.7.1 Company Profile
  3.7.2 Main Business/Business Overview
  3.7.3 Products, Services and Solutions
  3.7.4 Drugs For Herpes Labialis (Oral Herpes) Revenue (Value) (2012-2017)
  3.7.5 Recent Developments
3.8 Livzon
  3.8.1 Company Profile
  3.8.2 Main Business/Business Overview
  3.8.3 Products, Services and Solutions
  3.8.4 Drugs For Herpes Labialis (Oral Herpes) Revenue (Value) (2012-2017)
  3.8.5 Recent Developments
3.9 Luoxin
  3.9.1 Company Profile
  3.9.2 Main Business/Business Overview
  3.9.3 Products, Services and Solutions
  3.9.4 Drugs For Herpes Labialis (Oral Herpes) Revenue (Value) (2012-2017)
  3.9.5 Recent Developments
3.10 Med shine
  3.10.1 Company Profile
  3.10.2 Main Business/Business Overview
  3.10.3 Products, Services and Solutions
  3.10.4 Drugs For Herpes Labialis (Oral Herpes) Revenue (Value) (2012-2017)
  3.10.5 Recent Developments
3.11 Bayer (Campho Phenique)
3.12 Blistex
3.13 Kelun Group
3.14 Hikma
3.15 Haiwang
3.16 Carmex
3.17 Cipher

4 GLOBAL DRUGS FOR HERPES LABIALIS (ORAL HERPES) MARKET SIZE BY TYPE AND APPLICATION (2012-2017)

4.1 Global Drugs For Herpes Labialis (Oral Herpes) Market Size by Type (2012-2017)
4.2 Global Drugs For Herpes Labialis (Oral Herpes) Market Size by Application (2012-2017)
4.3 Potential Application of Drugs For Herpes Labialis (Oral Herpes) in Future
4.4 Top Consumer/End Users of Drugs For Herpes Labialis (Oral Herpes)

5 UNITED STATES DRUGS FOR HERPES LABIALIS (ORAL HERPES) DEVELOPMENT STATUS AND OUTLOOK

5.1 United States Drugs For Herpes Labialis (Oral Herpes) Market Size (2012-2017)
5.2 United States Drugs For Herpes Labialis (Oral Herpes) Market Size and Market Share by Players (2016 and 2017)

6 EU DRUGS FOR HERPES LABIALIS (ORAL HERPES) DEVELOPMENT STATUS AND OUTLOOK

6.1 EU Drugs For Herpes Labialis (Oral Herpes) Market Size (2012-2017)
6.2 EU Drugs For Herpes Labialis (Oral Herpes) Market Size and Market Share by Players (2016 and 2017)

7 JAPAN DRUGS FOR HERPES LABIALIS (ORAL HERPES) DEVELOPMENT STATUS AND OUTLOOK

7.1 Japan Drugs For Herpes Labialis (Oral Herpes) Market Size (2012-2017)
7.2 Japan Drugs For Herpes Labialis (Oral Herpes) Market Size and Market Share by Players (2016 and 2017)

8 CHINA DRUGS FOR HERPES LABIALIS (ORAL HERPES) DEVELOPMENT STATUS AND OUTLOOK

8.1 China Drugs For Herpes Labialis (Oral Herpes) Market Size (2012-2017)
8.2 China Drugs For Herpes Labialis (Oral Herpes) Market Size and Market Share by Players (2016 and 2017)

9 INDIA DRUGS FOR HERPES LABIALIS (ORAL HERPES) DEVELOPMENT STATUS AND OUTLOOK

9.1 India Drugs For Herpes Labialis (Oral Herpes) Market Size (2012-2017)
9.2 India Drugs For Herpes Labialis (Oral Herpes) Market Size and Market Share by Players (2016 and 2017)

10 SOUTHEAST ASIA DRUGS FOR HERPES LABIALIS (ORAL HERPES) DEVELOPMENT STATUS AND OUTLOOK

10.1 Southeast Asia Drugs For Herpes Labialis (Oral Herpes) Market Size (2012-2017)
10.2 Southeast Asia Drugs For Herpes Labialis (Oral Herpes) Market Size and Market Share by Players (2016 and 2017)

11 MARKET FORECAST BY REGIONS, TYPE AND APPLICATION (2017-2022)

11.1 Global Drugs For Herpes Labialis (Oral Herpes) Market Size (Value) by Regions (2017-2022)
  11.1.1 United States Drugs For Herpes Labialis (Oral Herpes) Revenue and Growth Rate (2017-2022)
  11.1.2 EU Drugs For Herpes Labialis (Oral Herpes) Revenue and Growth Rate (2017-2022)
  11.1.3 Japan Drugs For Herpes Labialis (Oral Herpes) Revenue and Growth Rate (2017-2022)
  11.1.4 China Drugs For Herpes Labialis (Oral Herpes) Revenue and Growth Rate (2017-2022)
  11.1.5 India Drugs For Herpes Labialis (Oral Herpes) Revenue and Growth Rate (2017-2022)
  11.1.6 Southeast Asia Drugs For Herpes Labialis (Oral Herpes) Revenue and Growth Rate (2017-2022)
11.2 Global Drugs For Herpes Labialis (Oral Herpes) Market Size (Value) by Type (2017-2022)
11.3 Global Drugs For Herpes Labialis (Oral Herpes) Market Size by Application (2017-2022)

12 DRUGS FOR HERPES LABIALIS (ORAL HERPES) MARKET DYNAMICS

12.1 Drugs For Herpes Labialis (Oral Herpes) Market Opportunities
12.2 Drugs For Herpes Labialis (Oral Herpes) Challenge and Risk
  12.2.1 Competition from Opponents
  12.2.2 Downside Risks of Economy
12.3 Drugs For Herpes Labialis (Oral Herpes) Market Constraints and Threat
  12.3.1 Threat from Substitute
  12.3.2 Government Policy
  12.3.3 Technology Risks
12.4 Drugs For Herpes Labialis (Oral Herpes) Market Driving Force
  12.4.1 Growing Demand from Emerging Markets
  12.4.2 Potential Application

13 MARKET EFFECT FACTORS ANALYSIS

13.1 Technology Progress/Risk
  13.1.1 Substitutes
  13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
  13.3.1 Economic Fluctuations
  13.3.2 Other Risk Factors

14 RESEARCH FINDING/CONCLUSION

15 APPENDIX

Methodology
Analyst Introduction
Data Source


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Drugs For Herpes Labialis (Oral Herpes) Product Scope
Figure Global Drugs For Herpes Labialis (Oral Herpes) Market Size (Million USD) (2012-2017)
Table Global Drugs For Herpes Labialis (Oral Herpes) Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Drugs For Herpes Labialis (Oral Herpes) Market Share by Regions in 2016
Figure United States Drugs For Herpes Labialis (Oral Herpes) Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure EU Drugs For Herpes Labialis (Oral Herpes) Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Japan Drugs For Herpes Labialis (Oral Herpes) Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure China Drugs For Herpes Labialis (Oral Herpes) Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure India Drugs For Herpes Labialis (Oral Herpes) Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Southeast Asia Drugs For Herpes Labialis (Oral Herpes) Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Drugs For Herpes Labialis (Oral Herpes) Market Share by Type in 2016
Figure Valacyclovir Market Size (Million USD) and Growth Rate (2012-2017)
Figure Aciclovir Market Size (Million USD) and Growth Rate (2012-2017)
Figure Famciclovir Market Size (Million USD) and Growth Rate (2012-2017)
Figure Docosanol Market Size (Million USD) and Growth Rate (2012-2017)
Figure Other Market Size (Million USD) and Growth Rate (2012-2017)
Figure Global Drugs For Herpes Labialis (Oral Herpes) Market Share by Application in 2016
Table Key Downstream Customer in External Use
Figure Drugs For Herpes Labialis (Oral Herpes) Market Size (Million USD) and Growth Rate in External Use (2012-2017)
Table Key Downstream Customer in Oral
Figure Drugs For Herpes Labialis (Oral Herpes) Market Size (Million USD) and Growth Rate in Oral (2012-2017)
Table Key Downstream Customer in Injection
Figure Drugs For Herpes Labialis (Oral Herpes) Market Size (Million USD) and Growth Rate in Injection (2012-2017)
Table Drugs For Herpes Labialis (Oral Herpes) Market Size (Million USD) by Players (2016 and 2017)
Figure Drugs For Herpes Labialis (Oral Herpes) Market Size Share by Players in 2016
Figure Drugs For Herpes Labialis (Oral Herpes) Market Size Share by Players in 2017
Table GSK Basic Information List
Table Drugs For Herpes Labialis (Oral Herpes) Business Revenue (Million USD) of GSK (2012-2017)
Figure GSK Drugs For Herpes Labialis (Oral Herpes) Business Revenue Market Share in 2016
Table Novartis Basic Information List
Table Drugs For Herpes Labialis (Oral Herpes) Business Revenue (Million USD) of Novartis (2012-2017)
Figure Novartis Drugs For Herpes Labialis (Oral Herpes) Business Revenue Market Share in 2016
Table Teva Basic Information List
Table Drugs For Herpes Labialis (Oral Herpes) Business Revenue (Million USD) of Teva (2012-2017)
Figure Teva Drugs For Herpes Labialis (Oral Herpes) Business Revenue Market Share in 2016
Table Mylan Basic Information List
Table Drugs For Herpes Labialis (Oral Herpes) Business Revenue (Million USD) of Mylan (2012-2017)
Figure Mylan Drugs For Herpes Labialis (Oral Herpes) Business Revenue Market Share in 2016
Table Cadila Basic Information List
Table Drugs For Herpes Labialis (Oral Herpes) Business Revenue (Million USD) of Cadila (2012-2017)
Figure Cadila Drugs For Herpes Labialis (Oral Herpes) Business Revenue Market Share in 2016
Table Apotex Basic Information List
Table Drugs For Herpes Labialis (Oral Herpes) Business Revenue (Million USD) of Apotex (2012-2017)
Figure Apotex Drugs For Herpes Labialis (Oral Herpes) Business Revenue Market Share in 2016
Table Daewoong Pharmaceutical Basic Information List
Table Drugs For Herpes Labialis (Oral Herpes) Business Revenue (Million USD) of Daewoong Pharmaceutical (2012-2017)
Figure Daewoong Pharmaceutical Drugs For Herpes Labialis (Oral Herpes) Business Revenue Market Share in 2016
Table Livzon Basic Information List
Table Drugs For Herpes Labialis (Oral Herpes) Business Revenue (Million USD) of Livzon (2012-2017)
Figure Livzon Drugs For Herpes Labialis (Oral Herpes) Business Revenue Market Share in 2016
Table Luoxin Basic Information List
Table Drugs For Herpes Labialis (Oral Herpes) Business Revenue (Million USD) of Luoxin (2012-2017)
Figure Luoxin Drugs For Herpes Labialis (Oral Herpes) Business Revenue Market Share in 2016
Table Med shine Basic Information List
Table Drugs For Herpes Labialis (Oral Herpes) Business Revenue (Million USD) of Med shine (2012-2017)
Figure Med shine Drugs For Herpes Labialis (Oral Herpes) Business Revenue Market Share in 2016
Table Bayer (Campho Phenique) Basic Information List
Table Drugs For Herpes Labialis (Oral Herpes) Business Revenue (Million USD) of Bayer (Campho Phenique) (2012-2017)
Figure Bayer (Campho Phenique) Drugs For Herpes Labialis (Oral Herpes) Business Revenue Market Share in 2016
Table Blistex Basic Information List
Table Drugs For Herpes Labialis (Oral Herpes) Business Revenue (Million USD) of Blistex (2012-2017)
Figure Blistex Drugs For Herpes Labialis (Oral Herpes) Business Revenue Market Share in 2016
Table Kelun Group Basic Information List
Table Drugs For Herpes Labialis (Oral Herpes) Business Revenue (Million USD) of Kelun Group (2012-2017)
Figure Kelun Group Drugs For Herpes Labialis (Oral Herpes) Business Revenue Market Share in 2016
Table Hikma Basic Information List
Table Drugs For Herpes Labialis (Oral Herpes) Business Revenue (Million USD) of Hikma (2012-2017)
Figure Hikma Drugs For Herpes Labialis (Oral Herpes) Business Revenue Market Share in 2016
Table Haiwang Basic Information List
Table Drugs For Herpes Labialis (Oral Herpes) Business Revenue (Million USD) of Haiwang (2012-2017)
Figure Haiwang Drugs For Herpes Labialis (Oral Herpes) Business Revenue Market Share in 2016
Table Carmex Basic Information List
Table Drugs For Herpes Labialis (Oral Herpes) Business Revenue (Million USD) of Carmex (2012-2017)
Figure Carmex Drugs For Herpes Labialis (Oral Herpes) Business Revenue Market Share in 2016
Table Cipher Basic Information List
Table Drugs For Herpes Labialis (Oral Herpes) Business Revenue (Million USD) of Cipher (2012-2017)
Figure Cipher Drugs For Herpes Labialis (Oral Herpes) Business Revenue Market Share in 2016
Table Global Drugs For Herpes Labialis (Oral Herpes) Market Size (Million USD) by Type (2012-2017)
Figure Global Drugs For Herpes Labialis (Oral Herpes) Market Size Share by Type in 2012
Figure Global Drugs For Herpes Labialis (Oral Herpes) Market Size Share by Type in 2013
Figure Global Drugs For Herpes Labialis (Oral Herpes) Market Size Share by Type in 2014
Figure Global Drugs For Herpes Labialis (Oral Herpes) Market Size Share by Type in 2015
Figure Global Drugs For Herpes Labialis (Oral Herpes) Market Size Share by Type in 2016
Figure Global Drugs For Herpes Labialis (Oral Herpes) Market Size Share by Type in 2017
Table Global Drugs For Herpes Labialis (Oral Herpes) Market Size (Million USD) by Application (2012-2017)
Figure Global Drugs For Herpes Labialis (Oral Herpes) Market Size (Million USD) by Application in 2012
Figure Global Drugs For Herpes Labialis (Oral Herpes) Market Size (Million USD) by Application in 2013
Figure Global Drugs For Herpes Labialis (Oral Herpes) Market Size (Million USD) by Application in 2014
Figure Global Drugs For Herpes Labialis (Oral Herpes) Market Size (Million USD) by Application in 2015
Figure Global Drugs For Herpes Labialis (Oral Herpes) Market Size (Million USD) by Application in 2016
Figure Global Drugs For Herpes Labialis (Oral Herpes) Market Size (Million USD) by Application in 2017
Table Top Consumer/End Users of Drugs For Herpes Labialis (Oral Herpes)
Figure United States Drugs For Herpes Labialis (Oral Herpes) Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table United States Drugs For Herpes Labialis (Oral Herpes) Market Size (Million USD) by Players (2012-2017)
Figure United States Drugs For Herpes Labialis (Oral Herpes) Market Size Share by Players in 2016
Figure United States Drugs For Herpes Labialis (Oral Herpes) Market Size Share by Players in 2017
Figure EU Drugs For Herpes Labialis (Oral Herpes) Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table EU Drugs For Herpes Labialis (Oral Herpes) Market Size (Million USD) by Players (2012-2017)
Figure EU Drugs For Herpes Labialis (Oral Herpes) Market Size Share by Players in 2016
Figure EU Drugs For Herpes Labialis (Oral Herpes) Market Size Share by Players in 2017
Figure Japan Drugs For Herpes Labialis (Oral Herpes) Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Japan Drugs For Herpes Labialis (Oral Herpes) Market Size (Million USD) by Players (2012-2017)
Figure Japan Drugs For Herpes Labialis (Oral Herpes) Market Size Share by Players in 2016
Figure Japan Drugs For Herpes Labialis (Oral Herpes) Market Size Share by Players in 2017
Figure China Drugs For Herpes Labialis (Oral Herpes) Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table China Drugs For Herpes Labialis (Oral Herpes) Market Size (Million USD) by Players (2012-2017)
Figure China Drugs For Herpes Labialis (Oral Herpes) Market Size Share by Players in 2016
Figure China Drugs For Herpes Labialis (Oral Herpes) Market Size Share by Players in 2017
Figure India Drugs For Herpes Labialis (Oral Herpes) Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table India Drugs For Herpes Labialis (Oral Herpes) Market Size (Million USD) by Players (2012-2017)
Figure India Drugs For Herpes Labialis (Oral Herpes) Market Size Share by Players in 2016
Figure India Drugs For Herpes Labialis (Oral Herpes) Market Size Share by Players in 2017
Figure Southeast Asia Drugs For Herpes Labialis (Oral Herpes) Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Southeast Asia Drugs For Herpes Labialis (Oral Herpes) Market Size (Million USD) by Players (2012-2017)
Figure Southeast Asia Drugs For Herpes Labialis (Oral Herpes) Market Size Share by Players in 2016
Figure Southeast Asia Drugs For Herpes Labialis (Oral Herpes) Market Size Share by Players in 2017
Figure Global Drugs For Herpes Labialis (Oral Herpes) Market Size (Million USD) by Regions (2017-2022)
Table Global Drugs For Herpes Labialis (Oral Herpes) Market Size (Million USD) by Regions (2017-2022)
Figure Global Drugs For Herpes Labialis (Oral Herpes) Market Size Share by Regions in 2017
Figure Global Drugs For Herpes Labialis (Oral Herpes) Market Size Share by Regions in 2022
Figure United States Drugs For Herpes Labialis (Oral Herpes) Revenue (Million USD) and Growth Rate (2017-2022)
Figure EU Drugs For Herpes Labialis (Oral Herpes) Revenue (Million USD) and Growth Rate (2017-2022)
Figure Japan Drugs For Herpes Labialis (Oral Herpes) Revenue (Million USD) and Growth Rate (2017-2022)
Figure China Drugs For Herpes Labialis (Oral Herpes) Revenue (Million USD) and Growth Rate (2017-2022)
Figure India Drugs For Herpes Labialis (Oral Herpes) Revenue (Million USD) and Growth Rate (2017-2022)
Figure Southeast Asia Drugs For Herpes Labialis (Oral Herpes) Revenue (Million USD) and Growth Rate (2017-2022)
Table Global Drugs For Herpes Labialis (Oral Herpes) Market Size (Million USD) by Type (2017-2022)
Figure Global Drugs For Herpes Labialis (Oral Herpes) Market Size Share by Type in 2017
Figure Global Drugs For Herpes Labialis (Oral Herpes) Market Size Share by Type in 2022
Table Global Drugs For Herpes Labialis (Oral Herpes) Market Size (Million USD) by Application (2017-2022)
Figure Global Drugs For Herpes Labialis (Oral Herpes) Market Size (Million USD) by Application in 2017
Figure Global Drugs For Herpes Labialis (Oral Herpes) Market Size (Million USD) by Application in 2022